I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia"
This is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orally once daily in pediatric patients with newly diagnosed chronic phase Ph+ CML (ND CML) and pediatric patients with Ph+CML who have received at least one prior TKI therapy (R/I CML), …
molecular diagnosis
differentiation therapy
blastic phase chronic myeloid leukemia
t315i mutation
renal function
- 0 views
- 19 Feb, 2024